Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02218840 · ClinicalTrials.gov registry record
Behavioral Pharmacology Associated With Cigar Smoking
A clinical trial, sponsored by Food and Drug Administration (FDA).
- Completed
- Registry status
- 77
- Enrollment target
NCT02218840 is a clinical trial that has completed, run by Food and Drug Administration (FDA). The registered enrollment target is 77 participants.
The verdict
NCT02218840 has completed, sponsored by Food and Drug Administration (FDA).
- COMPLETED
- Registry status
- 77 participants
- Enrollment target
Study Summary
Lovelace Scientific Resources is conducting clinical research study for cigar smokers. This study will be evaluating the behaviors of cigar smokers and the short term effects of cigar smoking. A cigar is defined as a cylinder of tobacco wrapped in a tobacco leaf for smoking. There are small cigars with filters that resemble cigarettes and large cigars that do not have filters. Because cigars come in so many shapes and sizes, the nicotine content varies as well. The way that a cigar smoker consumes the cigar can also have an effect on how much nicotine is absorbed. This study seeks to understand nicotine consumption and addiction in cigar smokers. Study participation will last 1 to 4 weeks and will include 2 study-related visits. Your visits may include a physical exam, medical history review, questionnaires, blood collections, providing a urine sample, an exhaled breath test, having your vital signs collected and smoking a cigar. You will be videotaped while you smoke your cigar so that we can review the technique you use while smoking. STUDY HYPOTHESES: * Significant reductions in craving and withdrawal will be reported after ad libitum smoking of a cigar compared to self-report prior to cigar smoking. * Cigar smokers will show a range of nicotine dependence, with a subset of users exceeding minimal criteria for nicotine dependence. * Levels of nicotine, cotinine, Carbon Monoxide (CO), and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) will increase significantly from pre- to post-cigar smoking. * Small cigar/cigarillo users will demonstrate greater levels of dependence and greater relief from craving and withdrawal compared to large cigar users.
Interventions
- OTHER Smoking topography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2014-04 |
| Est. Completion | 2016-03-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02218840
The ClinicalTrials.gov registry entry for NCT02218840 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Food and Drug Administration (FDA), which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Smoking topography is the first listed.
NCT02218840 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02218840 about?
NCT02218840 is a clinical study titled "Behavioral Pharmacology Associated With Cigar Smoking". Lovelace Scientific Resources is conducting clinical research study for cigar smokers. This study will be evaluating the behaviors of cigar smokers and the short term effects of cigar smoking. A cigar is defined as a cylinder of tobacco wrapped in a tobacco leaf for smoking. There are small cigars ...
What is the current status of trial NCT02218840?
This trial is currently completed. The enrollment target is 77 participants. The study started on 2014-04. Estimated completion is 2016-03-02.
What interventions are being tested in trial NCT02218840?
The interventions under investigation include: Smoking topography (OTHER).
Who is sponsoring clinical trial NCT02218840?
This trial is sponsored by Food and Drug Administration (FDA), which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.